PERSONALIZED GENOMICS MARKET ANALYSIS

Personalized Genomics Market, By Test Type (Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Others), By Technology (PCR-based Tests, Microarray-based Tests, Sequencing-based Tests, Others), By Application (Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition & Health Lifestyle, Others), By End User (Hospitals & Clinics, Research Centers, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In August 2020, Ancestry a genealogy comapny launched AncestryHealth+, providing consumers access to genetic counselors to understand health reports and family health history features.
In December 2020, Helix, a genomics company, announced partnership with Emedgene a genomic platform provider to offer genetic testing services for inherited retinal diseases.

In January 2022, Exact Sciences, a molecular diagnostics company, acquired Preventiongenetics a testing laboratories to expand access to genetic testing services and enhance hereditary cancer testing capabilities.
In May 2022, CytoReason, a biotechnology company, entered a collaboration with Pfizer a pharmaceutical company to identify new drug targets and biomarkers focused on cardiovascular diseases using genomic data.
In January 2020, Quest Diagnostics, a medical laboratories company, acquired Blueprint Genetics genetic testing company to enhance and scale advanced sequencing capabilities.